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Background: Delayed haemorrhage (DH) is a life-threatening complication of pancreatic resection (PR)
and the mortality rate for DH is very high. However, the risk factors and prognostic factors associated with
DH are rarely evaluated.
Methods: A pancreatic resection was performed on 457 patients. Delayed haemorrhage was defined as
bleeding from the surgical site 5 days after PR. Risk factors for DH were assessed according to
demographics and pathological and operative parameters. Prognostic factors after DH were evaluated for
the shock index (heart rate/systolic blood pressure) and systemic inflammatory response syndrome
(SIRS) scores.
Results: Of the 457 patients, 11 (2.4%) experienced DH after PR. Logistic regression analysis showed
that age >60 years and a diagnosis of malignant disease were risk factors for DH. The shock index and
SIRS scores at the onset of DH were significantly higher in patients who died as compared with those
patients that survived (P < 0.05).
Discussion: PR-associated DH carries an increased risk for patients aged >60 years with malignant
disease. Prognostic factors were a shock index score 0.7 and SIRS at the onset of DH.
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Introduction
The mortality rate after pancreatic surgery has been decreasing
over the past decade, especially in high-volume centres, and is
currently below 5%.1–3 This decreased rate has led to an increase in
the number of patients undergoing pancreatic resection (PR).4 In
spite of progression of surgical techniques and peri-operative
management for pancreatic surgery, morbidity is still high, with a
rate of 18–54%.1,5–9 The most frequent complications after PR are
delayed gastric empting, pancreatic leakage and local infection.10
Haemorrhage after PR occurs in 2–15% of patients in the early
or late postoperative phase,8,11 but is one of the most serious
complications with a mortality rate of 15–58%.8,12 In particular,
delayed haemorrhage (DH), which is a life-threatening complica-
tion after PR, is rarely reported.1,9,11,13–18
The development of a systemic inflammatory response syn-
drome (SIRS) response has been shown to be an early warning
sign of underlying problems in surgical patients.19,20 However, the
relationship between DH after PR and a SIRS response or a con-
comitant poor score on the shock index21 is unclear. Therefore, the
aim of this study was to evaluate the risk factors of PR-associated
DH and the prognostic factors after DH.
Patients and methods
The clinical records of all patients who underwent PR were retro-
spectively analysed with regard to DH after PR. All patients pro-
vided written informed consent to participate before undergoing
surgery. Delayed haemorrhage was defined as bleeding from the
surgical site 5 days after PR, and this was further restricted to
patients that required a blood transfusion >2 U of packed red
blood cells, intensive treatment such as laparotomy or transarte-
rial embolization (TAE) and surgical intensive care unit supervi-
sion. In all patients, initial management involved transarterial
embolization; if haemostasis was not achieved, patients proceeded
to laparotomy. Risk factors for DH after PR were assessed
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according to demographics, pathological diagnosis and operative
procedure. Prognostic factors after DH were evaluated for the
following variables: shock index score, SIRS score, C-reactive
protein and white blood cells at the onset of hemorrhage. The
shock index was defined as heart rate divided by systolic blood
pressure.21 For SIRS scoring, the method originally described
by Bone et al. was used.22 Briefly, the four criteria of SIRS are
as follows: (i) white blood cell count >12 000 cells/mm3, or
<4000 cells/mm3, or >10% cells with immature form; (ii) tem-
perature >38°C or <36°C; (iii) heart rate >90 beats per minute;
and (iv) respiratory rate >20 breaths per minute or PaCO2
< 32 mm Hg. According to these criteria, patients were given a
SIRS score of 0–4 at the onset of haemorrhage. SIRS is defined by
the presence of 2 of the criteria. In this study, a post-operative
pancreatic fistula (POPF) was defined and classified using
the International Study Group on Pancreatic Fistula (ISGPF)
criteria.23
Risk factors for DH and prognostic factors after DH were inves-
tigated using logistic regression analysis. A statistical difference
was considered significant at P < 0.05.
Results
Patients with DH after PR
A pancreatic resection was performed on 457 patients [206 (45%)
female, with a median (range) age of 66 (14–87) years] at Kuma-
moto University between February 1989 and February 2010. Of
these 457 patients, 11 [2.4%; 4 female; median (range) age 73
(61–79) years] experienced DH. Delayed haemorrhage was expe-
rienced at a median (range) 18 (8–39) days after PR. A prompt
laparotomy and haemostasis was performed in 4 patients; 1 sur-
vived, but 3 died within 74 days, with a median survival time of
29 days after reoperation. Transarterial embolization was per-
formed in 7 patients, including a sequential laparotomy in 2
patients; 3 survived, but 2 died within 205 days after transarterial
embolization. Haemorrhage foci were peripancreatic arteries in
10 patients (superior mesenteric artery in 1, common hepatic
artery in 1, proper hepatic artery in 1, splenic artery in 4, left
gastric artery in 2, and middle hepatic artery in 1) and the pan-
creaticogastrostomy site in 1 patient. Pancreatic cancer was diag-
nosed in 7 patients, bile duct cancer in 2, an endocrine tumour of
the pancreas in 1 and gallbladder cancer in 1. All patients who
experienced DH had a pancreatic fistula ISGPF grade B before
DH.
Risk factors associated with DH after PR
Risk factors associated with DH after PR were assessed. All 11
patients with DH were >60 years and age was found to be a sig-
nificant risk factor (P = 0.018). Moreover, all patients with DH had
been diagnosed with malignant disease, which also proved to be a
significant risk factor (P = 0.001). Other parameters, including
gender and operative procedure, were not risk factors statistically.
Prognostic factors after DH
Prognostic factors were evaluated after DH. The mean shock
index at the onset of DH was 0.6 (0.4–0.8) in those patients who
survived, compared with 1.1 (0.7–1.9) in those patients who died
(Fig. 1) (P = 0.046). The SIRS score was 0 and 1 in those patients
that survived and from 1 to 4 in those patients that died (Fig. 2)
(P = 0.05), indicating that all patients who died after DH were
diagnosed with SIRS at the onset. Logistic regression analysis
revealed that the shock index and SIRS scores were significant
prognostic factors after DH (P = 0.001).
The C-reactive protein at onset of DH was a median (range)
2.98 mg/dl (2.27–14.32) in patients who survived compared with
3.35 mg/dl (1.60–11.36) in those patients that died (P = 0.988).
The median (range) white blood cell count at onset of DH was a
P = 0.046
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Figure 1 Correlation of the shock index score between recovered
and expired patients. The shock index score was significantly lower
in recovered patients than in expired patients (P = 0.001)
P = 0.05
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Figure 2 Correlation of systemic inflammatory response syndrome
(SIRS) score between recovered and expired patients. The SIRS
score was significantly lower in recovered patients than in expired
patients (P = 0.001). All expired patients experienced SIRS at the
onset of delayed haemorrhage
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median 10 600 (8100–13 600 cells/mm3) in patients that survived
compared with 12 300 (7000–15200) in those patients that died
(P = 0.916).
Discussion
The aim of this study was to clarify the incidence of DH after PR
and to subsequently evaluate the risk factors for DH and the
prognostic factors after haemorrhage. Only a few previous studies
have focused on DH after PR and have revealed that post-
operative arterial bleeding occurs in the range of 2% to
4%.1,9,11,13–18 In the present study, the DH rate was 2.4% with a
mortality rate of 63.6%.
Haemorrhage within the first 24 h of surgery is usually caused
by intra-operative technical failure, including failure to induce
haemostasis, and requires immediate haemostasis under reopera-
tion. Delayed haemorrhage is commonly related to an anasto-
motic leak and/or local infection, subsequent development of
erosion and/or pseudoaneurysm of the peri-pancreatic ves-
sels.11,24,25 All patients with DH in the present study suffered a
pancreatic fistula with local infection. Anastomotic leak can lead
to many post-operative complications, including a pancreatic
fistula and intra-abdominal abscess formation.26 Aggressive pan-
creatic juice leaking from an anastomosis may directly erode the
vessel wall.
The present results revealed that one of the risk factors for DH
after PR is a pathological diagnosis of malignant disease. Patients
with malignant disease often have undergone a systematic lym-
phadenectomy, including skeletonization of peripancreatic vis-
ceral arteries. In such patients, tissue covering the vessels is
removed during surgery, which might expose the adventitia to
aggressive pancreatic juice and/or local infection in patients with
an anastomotic leak.
Age >60 years was also shown to be a risk factor of DH after PR.
The elderly experience normal physiological changes associated
with ageing in all organs and systems, and these changes lead to
diminished physiological reserve.27 Pedersen et al. revealed that
patients with advanced age have the highest mortality rate within
the adult surgical population.28 Surgical complications that lead to
reoperation are responsible for the high mortality in elderly
patients with pancreatic head carcinoma.29 The elderly, especially
those with malignant disease, should be considered to have
reduced functional reserve and poor tolerance to stress.
The evaluation of prognostic factors after DH revealed that all
patients with a shock index score 0.7 and with SIRS at onset of
DH expired after haemorrhage, indicating that patients who died
experienced not only local failure but also systemic disorder,
including a shock state with systemic inflammation. The only
warning sign of DH observed among the patients in this study was
the appearance of fluid in the drain turning bloody (i.e. sentinel
bleed). We also checked the colour and amylase content in the
fluid, and whether there were signs of infection in cultured cells,
but these were not indicators of DH.
In conclusion, in patients with DH after PR, the mortality rate
will be high if the SIRS score and shock index score are poor.
The risk factors for DH are age >60 years and malignant disease.
Prognostic factors were a shock index score 0.7 and SIRS at
onset of DH.
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